carnitine has been researched along with Hepatitis B in 3 studies
Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The outcome of hepatitis B virus (HBV) infection is significantly affected by host immune response; herein, we aim to dissect the effect of L-carnitine (L-Cn) on germinal center (GC)-related immune cells and the influence on the prognosis of HBV infection." | 8.12 | Hepatocyte-Derived L-Carnitine Restricts Hepatitis B Surface Antigen Loss Through an Immunosuppressive Effect on Germinal Center-Related Immune Cells. ( Chen, C; Fu, X; Gu, S; Guo, L; Hou, J; Li, X; Li, Y; Sun, J; Tang, L; Wang, W; Wen, C; Ye, G; Zhong, S; Zhou, Y, 2022) |
| " Tenofovir dipivoxil, a novel ester prodrug of tenofovir, can be used for treatment for hepatitis B and HIV infection and it was necessary to evaluate the effect of its treatment on carnitine homeostasis." | 5.17 | Impact on L-carnitine Homeostasis of Short-term Treatment with the Pivalate Prodrug Tenofovir Dipivoxil. ( Feng, J; Hang, TJ; Jia, YY; Lu, CT; Song, Y; Sun, Y; Wang, S; Wen, AD; Yang, ZF; Zhao, JY, 2013) |
| "The outcome of hepatitis B virus (HBV) infection is significantly affected by host immune response; herein, we aim to dissect the effect of L-carnitine (L-Cn) on germinal center (GC)-related immune cells and the influence on the prognosis of HBV infection." | 4.12 | Hepatocyte-Derived L-Carnitine Restricts Hepatitis B Surface Antigen Loss Through an Immunosuppressive Effect on Germinal Center-Related Immune Cells. ( Chen, C; Fu, X; Gu, S; Guo, L; Hou, J; Li, X; Li, Y; Sun, J; Tang, L; Wang, W; Wen, C; Ye, G; Zhong, S; Zhou, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, S | 1 |
| Wang, W | 1 |
| Ye, G | 1 |
| Chen, C | 1 |
| Zhou, Y | 1 |
| Guo, L | 1 |
| Zhong, S | 1 |
| Li, X | 1 |
| Fu, X | 1 |
| Wen, C | 1 |
| Tang, L | 1 |
| Sun, J | 1 |
| Hou, J | 1 |
| Li, Y | 1 |
| Jia, YY | 1 |
| Lu, CT | 1 |
| Feng, J | 1 |
| Song, Y | 1 |
| Zhao, JY | 1 |
| Wang, S | 1 |
| Sun, Y | 1 |
| Wen, AD | 1 |
| Yang, ZF | 1 |
| Hang, TJ | 1 |
| Nakanishi, H | 1 |
| Kurosaki, M | 1 |
| Izumi, N | 1 |
1 trial available for carnitine and Hepatitis B
| Article | Year |
|---|---|
Impact on L-carnitine Homeostasis of Short-term Treatment with the Pivalate Prodrug Tenofovir Dipivoxil.
Topics: Adenine; Adult; Antiviral Agents; Carnitine; Dose-Response Relationship, Drug; Female; Hepatitis B; | 2013 |
2 other studies available for carnitine and Hepatitis B
| Article | Year |
|---|---|
Hepatocyte-Derived L-Carnitine Restricts Hepatitis B Surface Antigen Loss Through an Immunosuppressive Effect on Germinal Center-Related Immune Cells.
Topics: Animals; Carnitine; Germinal Center; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; H | 2022 |
[Antiviral effect of carnitine for chronic hepatitis or liver cirrhosis patients].
Topics: Antiviral Agents; Carnitine; Hepatitis B; Hepatitis C; Hepatitis, Chronic; Humans; Liver Cirrhosis | 2015 |